There are also reports for the role of RAC1 and RAC1B in chemotherapy and targeted therapy resistance in cancers such as melanoma, lung cancer, breast cancer, and thyroid cancer, and this has been reviewed elsewhere [45,47,50,51]. Here, RAC1 is linked to lung carcinoma.